Beringea provides £4.75m to Advent-backed firm

Advent-backed pharma company SEP has secured growth debt finance from Beringea.

15 January 2015•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.